As of 2025-07-09, the Fair Value of Checkpoint Therapeutics Inc (CKPT) is -3.23 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.26 USD, the upside of Checkpoint Therapeutics Inc is -175.86%.
With the market price of 4.26 USD and our fair value calculation, Checkpoint Therapeutics Inc (CKPT) is not a good investment. Investing in CKPT stocks now will result in a potential loss of 175.86%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -23.08 | -56.67 | -62.62 | -51.85 | -56.24 | -50.09 |
| YoY growth | 6.60% | -145.54% | -10.50% | 17.20% | -8.47% | -28.14% |
| Market Cap (mil) | 370.71 |
| P/E | |
| Forward P/E |
| EPS | -0.65 |
| Avg earnings growth rate | -28.14% |
| TTM earnings | -56.24 |